MAPK1 and cancer: The inhibition of mTORC1 was shown to activate the MAPK pathway through a PI3K-dependent feedback loop in human cancer [18], and rapalog resistance was associated with extracellular signal-regulated kinase 2 (ERK2) upregulation in a human NET cell line [19].